These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27386796)

  • 21. Safety and Efficacy in Prasugrel- Versus Ticagrelor-Treated Patients With ST-Elevation Myocardial Infarction.
    Dimitroulis D; Golabkesh M; Naguib D; Knoop B; Dannenberg L; Helten C; Pöhl M; Jung C; Kelm M; Zeus T; Polzin A
    J Cardiovasc Pharmacol; 2018 Oct; 72(4):186-190. PubMed ID: 29985284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH Study.
    Rollini F; Franchi F; Hu J; Kureti M; Aggarwal N; Durairaj A; Park Y; Seawell M; Cox-Alomar P; Zenni MM; Guzman LA; Suryadevara S; Antoun P; Bass TA; Angiolillo DJ
    J Am Coll Cardiol; 2016 May; 67(17):1994-2004. PubMed ID: 27012781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of oral P2Y12 inhibitors on residual thrombus burden and reperfusion indexes in patients with ST-segment elevation myocardial infarction.
    Di Vito L; Versaci F; Limbruno U; Pawlowski T; Gatto L; Romagnoli E; Cattabiani MA; Micari A; Trivisonno A; Marco V; Prati F
    J Cardiovasc Med (Hagerstown); 2016 Sep; 17(9):701-6. PubMed ID: 27467458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contemporary use of P2Y
    Rakowski T; Siudak Z; Dziewierz A; Plens K; Kleczyński P; Dudek D
    J Thromb Thrombolysis; 2018 Jan; 45(1):151-157. PubMed ID: 29075924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombogenicity and endothelial progenitor cells function during Acute myocardial infarction - comparison of Prasugrel versus Ticagrelor.
    Wiessman M; Kheifets M; Schamroth Pravda N; Leshem Lev D; Ziv E; Kornowski R; Spectre G; Perl L
    J Thromb Thrombolysis; 2023 Apr; 55(3):407-414. PubMed ID: 36598739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prehospital administration of P2Y12 inhibitors and early coronary reperfusion in primary PCI: an observational comparative study.
    De Backer O; Ratcovich H; Biasco L; Pedersen F; Helqvist S; Saunamäki K; Tilsted HH; Clemmensen P; Olivecrona G; Kelbaek H; Jørgensen E; Engstrøm T; Holmvang L
    Thromb Haemost; 2015 Aug; 114(3):623-31. PubMed ID: 25994355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial.
    Valgimigli M; Tebaldi M; Campo G; Gambetti S; Bristot L; Monti M; Parrinello G; Ferrari R;
    JACC Cardiovasc Interv; 2012 Mar; 5(3):268-77. PubMed ID: 22440491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial salvage after ST-segment-elevation myocardial infarction: comparison between prasugrel and clopidogrel in the presence or absence of high-residual platelet reactivity.
    Yoshida R; Takagi K; Ishii H; Morishima I; Tanaka A; Morita Y; Kanzaki Y; Nagai H; Watanabe N; Furui K; Shibata N; Yoshioka N; Yamauchi R; Komeyama S; Sugiyama H; Tsuboi H; Murohara T
    J Nucl Cardiol; 2021 Aug; 28(4):1422-1434. PubMed ID: 31428979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prehospital Prasugrel Versus Ticagrelor in Real-World Patients With ST-Elevation Myocardial Infarction Referred for Primary PCI: Procedural and 30-Day Outcomes.
    Vos NS; Amoroso G; Vink MA; Maarse M; Adams R; Herrman JR; Patterson MS; van der Schaaf RJ; Slagboom T; de Winter RJ
    J Invasive Cardiol; 2018 Dec; 30(12):431-436. PubMed ID: 30318484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of residual platelet reactivity on reperfusion in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Capranzano P; Capodanno D; Bucciarelli-Ducci C; Gargiulo G; Tamburino C; Francaviglia B; Ohno Y; La Manna A; Antonella S; Attizzani GF; Angiolillo DJ; Tamburino C
    Eur Heart J Acute Cardiovasc Care; 2016 Sep; 5(5):475-86. PubMed ID: 26758542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and pharmacodynamics of oral P2Y12 inhibitors during the acute phase of a myocardial infarction: A systematic review.
    Khan N; Cox AR; Cotton JM
    Thromb Res; 2016 Jul; 143():141-8. PubMed ID: 27259210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes Among Clopidogrel, Prasugrel, and Ticagrelor in ST-Elevation Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention From the TOTAL Trial.
    Welsh RC; Sidhu RS; Cairns JA; Lavi S; Kedev S; Moreno R; Cantor WJ; Stankovic G; Meeks B; Yuan F; Džavík V; Jolly SS
    Can J Cardiol; 2019 Oct; 35(10):1377-1385. PubMed ID: 31492492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of intravenous lysine acetylsalicylate versus oral aspirin on platelet responsiveness in patients with ST-segment elevation myocardial infarction: the ECCLIPSE-STEMI trial.
    Vivas D; Jiménez JJ; Martín-Asenjo R; Bernardo E; Ortega-Pozzi MA; Gómez-Polo JC; Moreno G; Vilacosta I; Pérez-Villacastín J; Fernández-Ortiz A
    J Thromb Thrombolysis; 2023 Feb; 55(2):203-210. PubMed ID: 36480147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-hospital ticagrelor in ST-segment elevation myocardial infarction: Ready for prime time?
    Alexopoulos D; Moulias A; Kanakakis I; Xanthopoulou I
    Int J Cardiol; 2015 Sep; 194():41-3. PubMed ID: 26011263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COMparison of Platelet reactivity following prAsugrel and ticagrelor loading dose in ST-Segment elevation myocardial infarctION patients: The COMPASSION study.
    Laine M; Gaubert M; Frère C; Peyrol M; Thuny F; Yvorra S; Chelini V; Bultez B; Luigi S; Mokrani Z; Bessereau J; Toesca R; Champenois A; Dignat-George F; Paganelli F; Bonello L
    Platelets; 2015; 26(6):570-2. PubMed ID: 25275609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence, Predictors, and Clinical Impact of Early Prasugrel Cessation in Patients With ST-Elevation Myocardial Infarction.
    Koskinas KC; Zanchin T; Klingenberg R; Gencer B; Temperli F; Baumbach A; Roffi M; Moschovitis A; Muller O; Tüller D; Stortecky S; Mach F; Lüscher TF; Matter CM; Pilgrim T; Heg D; Windecker S; Räber L
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29654204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of prasugrel pretreatment on angiographic myocardial perfusion parameters in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Perl L; Sasson L; Weissler-Snir A; Greenberg G; Vaknin-Assa H; Kornowski R; Assali A; Lev EI
    Coron Artery Dis; 2015 Dec; 26(8):665-70. PubMed ID: 26378953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High Platelet Reactivity in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Randomised Controlled Trial Comparing Prasugrel and Clopidogrel.
    Geisler T; Booth J; Tavlaki E; Karathanos A; Müller K; Droppa M; Gawaz M; Yanez-Lopez M; Davidson SJ; Stables RH; Banya W; Zaman A; Flather M; Dalby M
    PLoS One; 2015; 10(8):e0135037. PubMed ID: 26317618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry.
    Olivier CB; Diehl P; Schnabel K; Weik P; Zhou Q; Bode C; Moser M
    Thromb Haemost; 2014 Feb; 111(2):266-72. PubMed ID: 24172891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes in patients with ST-segment elevation acute myocardial infarction treated with clopidogrel versus prasugrel (from the INFUSE-AMI trial).
    Brener SJ; Oldroyd KG; Maehara A; El-Omar M; Witzenbichler B; Xu K; Mehran R; Gibson CM; Stone GW
    Am J Cardiol; 2014 May; 113(9):1457-60. PubMed ID: 24630789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.